Skip to content
Clinical Trials – home

Genital herpes simplex Diagnostics

1 / 1 trials open to patients2 countries

In short

Genital herpes simplex is a common sexually transmitted infection that can cause painful blisters or sores on the genitals, although many people have no symptoms at all. Understanding when and how to get tested for this infection is an important step in managing your sexual health and preventing transmission to partners.

Key points

  • Get tested promptly if you notice genital sores, blisters, or unusual symptoms—the fresher the lesion, the more accurate the test results will be.
  • Many people with genital herpes have no symptoms or such mild symptoms they don't recognize them, which is why specific testing is important if you're concerned about your status.
  • PCR testing from active sores is the gold standard for diagnosis, offering the highest accuracy in detecting and typing the herpes virus.
  • Blood tests can detect herpes when you don't have symptoms, but they require several weeks to months after infection to become positive and can't tell you where the infection is located.
  • Type-specific testing is crucial because it distinguishes between HSV-1 and HSV-2, which behave differently and have different implications for recurrence patterns.
  • Herpes testing isn't typically included in routine STI screenings—you need to specifically request it if you want to know your herpes status.
  • Testing negative doesn't always mean you don't have herpes, especially if you were tested too soon after exposure or if samples were taken from older lesions with low viral levels.
  • Clinical trials require specific diagnostic confirmation through laboratory testing to ensure accurate study results and participant safety.

Introduction: Who Should Get Tested and When

If you are sexually active, understanding when to seek testing for genital herpes can help you protect both your own health and that of your partners. You should consider getting tested if you notice any unusual symptoms in your genital area, such as small blisters, painful sores, or persistent itching and tingling around your genitals, anus, thighs, or buttocks. These symptoms might appear anywhere from two days to several weeks after you were exposed to the virus, though some people don't develop symptoms for months or even years after infection.

Testing becomes particularly important if your sexual partner tells you they have herpes or symptoms that could be herpes. Even if you feel completely healthy and have no visible sores, you might still benefit from testing, especially if you have had multiple sexual partners or are starting a new relationship. Many people with genital herpes don't know they have it because their symptoms are very mild or absent entirely, yet they can still spread the virus to others.

Pregnant women or those planning to become pregnant should discuss herpes testing with their healthcare provider, as the infection can potentially be passed to a baby during childbirth. Similarly, if you have HIV or another condition that weakens your immune system, getting tested for herpes is advisable because the infection may cause more severe symptoms in people with compromised immunity.

Classic Diagnostic Methods for Genital Herpes

Diagnosing genital herpes involves confirming that the herpes simplex virus (HSV) is present in your body and determining which type of virus is causing the infection. There are two types of herpes simplex virus: HSV-1 and HSV-2. While HSV-2 has traditionally been the main cause of genital herpes, HSV-1 (which more commonly causes cold sores around the mouth) can also cause genital infections, especially through oral sex.

Physical Examination

The first step in diagnosis usually involves a healthcare provider examining any visible sores or blisters. During this physical examination, your doctor will ask about your symptoms, your sexual history, and whether you or your partners have had herpes symptoms in the past. The appearance and location of the sores can often suggest genital herpes, but a physical exam alone cannot provide a definitive diagnosis. This is because other skin conditions can sometimes look similar to herpes, and the virus needs to be detected through laboratory testing to confirm the diagnosis.

Viral Testing from Sores

The most accurate way to diagnose genital herpes is to take a sample directly from an active blister or sore. This is called virologic testing. A healthcare provider will use a small cotton swab to collect fluid from the blister or scrape cells from the surface of a sore. This sample is then sent to a laboratory for analysis.

The preferred method for analyzing these samples is called nucleic acid amplification testing (NAAT), commonly known as PCR testing. This test looks for the genetic material of the herpes virus and is highly sensitive, meaning it can detect the virus even when only small amounts are present. NAAT tests are considered the most sensitive diagnostic tools available, with accuracy rates ranging from about 91% to 100%.

Another option is viral culture, where the sample is placed in special conditions that allow the virus to grow so it can be identified. However, viral culture is less sensitive than NAAT, especially if the sores have started to heal or if you're having a recurrent outbreak rather than your first episode. The virus is easier to detect when lesions are fresh and actively producing viral particles. Once the virus is identified through either method, the laboratory can determine whether it's HSV-1 or HSV-2.

It's important to understand that these tests can only be performed when visible blisters or sores are present. If you don't have any active lesions at the time of your medical visit, a swab test cannot be done. This is one reason why seeing a healthcare provider as soon as symptoms appear is so valuable.

Blood Testing for Herpes Antibodies

When you don't have visible sores, or if you want to know whether you've ever been infected with herpes even without symptoms, blood testing can be helpful. These are called serologic tests or antibody tests. When your body is infected with HSV, your immune system produces specific proteins called antibodies to fight the virus. These antibodies remain in your blood for the rest of your life, even when the virus is dormant and not causing symptoms.

Type-specific blood tests can distinguish between antibodies to HSV-1 and antibodies to HSV-2. The most accurate type-specific tests look for antibodies against a viral protein called glycoprotein G, which differs between HSV-1 and HSV-2. These tests can tell you which type of herpes virus you have been exposed to in the past.

However, blood tests have some limitations. It takes several weeks after infection for antibodies to develop to levels that can be detected. This period, called the window period, usually lasts between a few weeks to a few months. If you get tested too soon after being infected, the test might come back negative even though you have the virus. Additionally, blood tests can tell you that you have HSV somewhere in your body, but they cannot tell you where the infection is located or when you got it.

Blood testing is particularly useful if you want to know your herpes status when starting a new relationship, if your partner has been diagnosed with herpes, or if you have symptoms that could be herpes but no active sores to test. Some older types of blood tests that don't distinguish between HSV-1 and HSV-2 are less useful because they don't provide specific information about which type of virus you have.

Diagnostic Testing for Clinical Trial Participation

Clinical trials testing new treatments or prevention strategies for genital herpes have specific requirements for how participants are diagnosed and categorized. These standardized diagnostic criteria ensure that researchers are studying the right group of people and can accurately measure whether a new treatment is working.

For most clinical trials involving genital herpes, participants must have their infection confirmed through laboratory testing rather than just based on symptoms or physical examination alone. Trials typically require either a positive result from a viral test (such as PCR or culture) taken from an active sore, or a positive type-specific blood test showing antibodies to HSV-1 or HSV-2. This confirmation ensures that everyone in the study actually has genital herpes and hasn't been misdiagnosed with a different condition that might look similar.

Trials often distinguish between people having their first clinical episode of genital herpes and those who have recurrent outbreaks. The diagnostic criteria for enrollment may differ depending on which group is being studied. For first-episode studies, researchers typically want to include people who are experiencing their first outbreak of symptoms and can have a sample taken from active lesions for viral testing. For studies of recurrent herpes, participants generally need to have a documented history of multiple outbreaks, often six or more per year, confirmed either through medical records or positive antibody tests.

Some trials specifically enroll people based on whether they have HSV-2 or HSV-1 genital infection, as these two types behave differently. HSV-2 tends to cause more frequent recurrences in the genital area compared to HSV-1. Therefore, trials testing treatments to reduce outbreak frequency or viral shedding may specifically require participants to have HSV-2 confirmed through type-specific testing.

Clinical trials may also require participants to undergo baseline testing to measure how frequently they shed the virus without symptoms. This might involve collecting samples from the genital area daily for a period of time, even when no sores are present. These baseline measurements help researchers understand each participant's starting condition and measure changes during the trial.

If you are considering participating in a clinical trial for genital herpes, you should expect thorough diagnostic testing as part of the screening process. This may include physical examinations, swab tests if you have active lesions, blood tests to confirm your infection and identify the virus type, and possibly tests for other sexually transmitted infections. Researchers need this detailed information to ensure the trial is safe for you and that the results will be scientifically valid.

Did you know?

  1. Most people with genital herpes don't know they have it—estimates suggest that up to 90% of those infected with HSV-2 are unaware of their infection because they have no symptoms or very mild symptoms they don't recognize.
  2. The herpes virus can be detected from your cerebrospinal fluid if there's concern for brain or spinal cord infection, making PCR testing of spinal fluid the preferred method for diagnosing herpes meningitis or encephalitis.
  3. Blood tests cannot tell you where on your body you have herpes or when you got infected—they only confirm that HSV antibodies are present somewhere in your system, which is why testing active sores provides more specific information.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Genital herpes simplex

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:(S)-2-(2',5'-DIFLUORO-[1,1'-BIPHENYL]-4-YL)-N-METHYL-N-(4-METHYL-5-(S-METHYLSULFONIMIDOYL)THIAZOL-2-YL)ACETAMIDE
  • Sponsor:Innovative Molecules GmbH
See all 1 trials →filters applied: condition = Genital herpes simplex

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).